News

Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...
Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, ...
Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based ...
Indian equity benchmarks edged lower on Wednesday, mirroring weakness in Asian markets following a rise in US inflation.
Entresto is considered a cornerstone of Divi’s innovator-driven custom synthesis portfolio, contributing close to 40 percent ...
UTI MF sold aggressively in Infosys and in modest quantities in Reliance and Bharti Airtel. The fund’s top 5 stock picks for ...
Indian equity benchmarks edged lower on Wednesday, mirroring weakness in Asian markets following a rise in US inflation.
Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.
Anthem ticks all the boxes. But with lofty valuations and limited margin headroom, analysts warn the IPO may not deliver ...
AGNC Investment invests solely in mortgage-backed securities (MBS) protected from credit risk by government agencies like ...
Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...
The price band has been set at Rs 540 to Rs 570 per share. Investors can apply for a lot of 26 shares and in multiples of ...